# OnCo record concr (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/concr/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "concr" ;
  schema:name "Concr"@en ;
  schema:alternateName "Concr Ltd"@en, "FarrSight"@en ;
  schema:description "Concr builds a computer copy of an individual patient's cancer from their genetic, tissue and clinical data, and uses it to predict whether a given treatment is likely to work. It is testing those predictions in women with early triple-negative breast cancer."@en ;
  schema:url <https://onco.cc/companies/concr/>, <https://www.concr.co/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.concr.co/>, <https://www.enterprise.cam.ac.uk/case-studies/concr-applying-astrophysics-technology-to-predict-therapeutic-response-in-cancer/>, <https://www.samedanltd.com/press-releases/concr-launches-trial-using-digital-twins-for-outcome-prediction-in-breast-cancer/>, <https://find-and-update.company-information.service.gov.uk/company/11326653>, <https://clinicaltrials.gov/study/NCT06409221> ;
  schema:addressCountry "GB" ;
  onco:related <https://onco.cc/technologies/digital-twin-patient-models/> ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-cancer/> ;
  onco:sections <https://onco.cc/fronts/ai-computation/>, <https://onco.cc/fronts/drug-discovery/> ;
  onco:technologies <https://onco.cc/technologies/digital-twins-trials/> .